W FUND - Key Persons

Job Titles:

• CEO, Cardeas Pharma
• CEO, Cardeas Pharma, Former Senior Vice President, Gilead

An MD Pulmonologist/ Internist, Dr. Montgomery led translational research at Genentech. He was EVP of R&D and Regulatory Affairs at PathoGenesis, before founding Corus Pharma (acquired by Gilead Sciences in 2006). Post acquisition, he was Senior VP and head of Respiratory Therapeutics at Gilead. He has led six new drugs through FDA approval. The Seattle Post Intelligencer named him one of the three most influential leaders in Seattle's biotech industry. Dr. Montgomery has been a director for a number of local Biotechs, including Geospiza, Light Sciences Corporation, Zymogenetics, Alder and M3 biopharma. His trustee roles have included the Life Science Discovery Fund, the Army Science Board, and the Pacific Science Center. He is currently the CEO of Cardeas Pharma.

Job Titles:

• Board Member of the Washington Technology Alliance
• Managing Director, OVP

Chad Waite's investments include 4thPass, Accelerator, Adapx, Airgo Networks, Boston Beer, Cardima, CellPro, Complete Genomics, Corixa, Filenet, GenoLogics, Limerick BioPharma, Loudeye Technologies, NanoString, Napera Networks, ProTools, Quantum Medical, Raytel Medical, Returns Online, Rosetta Inpharmatics, SafeHarbor, Saros, Seattle Genetics, SignalSoft, Syntellect, Vantos, Verdezyne, Verity, and WatchGuard. He currently serves on the Board of Directors of Accelerator, Adapx, Complete Genomics, GenoLogics, Limerick BioPharma, NanoString and Verdezyne, and is a Board Observer to Talyst. Prior to joining OVP in 1987, Chad was a General Partner at Hambrecht & Quist Venture Partners where he focused on investments in IT and life sciences. Prior to H&Q, he was in marketing and sales management at Cobe Laboratories, Inc. in its cardiovascular medical products division. Chad is a board member of the Washington Technology Alliance, a member of the Oregon Health Sciences University (OHSU) BSIF Advisory Board and a member of the University of Washington's Technology Transfer Advisory Board.

Job Titles:

• Commercialization Consultant at Washington Biotechnology and Biomedical Association
• Serial Medical Device Entrepreneur and Commercialization Consultant at WBBA
• Trustee of the Seattle Biomedical Research Institute

Christopher Porter has had a successful 36-year career in the medical-device and biotechnology industry. He has been influential in introducing over 35 medical products, is the holder of 42 US patents and has started 6 medical-device companies. Chris has served in a variety of positions (CEO, General Manager, top technical and manufacturing positions) in both major corporations (3M, Johnson and Johnson, and Pfizer) and early stage medical companies. He has been an important part of creating in excess of $2 billion dollars in shareholder value. Chris has been a board member of numerous public and private companies. He has founded, invented products for, and contributed heavily to the success of numerous medical-device companies and started three divisions within major corporations. Chris currently serves as Trustee of the Seattle Biomedical Research Institute and serves on several advisory boards. He devotes much of his time towards assisting early-stage companies, mentoring, and participating in entrepreneurial education at the University of Utah, Seattle U and UW. Chris has a Ph.D. in Chemical and Material Engineering.

Job Titles:

• Managing Partner of EFund LLC

Daniel Kranzler is a wireless and technology industry entrepreneur who for 30 years has been managing, supporting, and financing start-up high tech companies. Since 1984, Daniel has been investing in, managing and advising communications and Internet tech startups. Daniel is a frequent speaker at wireless and technology conferences around the world including CES, GSM World Congress and numerous financial and technology conferences in the US, Europe and Asia. Daniel is currently Managing Partner of eFund LLC, a Venture Fund that invests in wireless and technology startups with profits of the fund going to children's charities through the Kirlin Charitable Foundation. Daniel is president of the Kirlin Charitable Foundation based in Washington State. The foundation started by the Kranzler family works as a catalyst and innovative partner in positive social change toward a vision of a global society, identified first and foremost by the grace of its empathy and compassion. Mr. Kranzler has been involved in a number of global conferences on peace, interfaith dialogue and compassion with global luminaries including the Dalai Lama, Archbishop Desmond Tutu and many others.

Job Titles:

• Director on the Boards
• Retired Senior Vice President of R & D, General Electric Co

Dr. Lonnie Edelheit's distinguished career at General Electric included ten years as GE's Senior Vice President of R&D and member of its Corporate Executive Council. His tenure included high technology product introductions throughout all of GE's businesses, including digital x-ray, improved ultrasound medical imagers, high-efficiency turbines for power generation, advanced lighting and electronics-based appliances, and weatherable plastics. He also led GE through significant advances in Internet applications, design for Six Sigma quality, e-business initiatives, and the development of Corporate R&D global technology centers. Earlier in his career, Lonnie made significant technical contributions to computed tomography (CT) x-ray systems and he helped move GE's radically new form of CT scanner quickly to market. He left GE for a period, to become President and CEO for Quantum Medical Systems, a venture capital-backed company that pioneered color-flow ultrasound for vascular imaging. Lonnie Led Quantum through a successful acquisition by Siemens. Lonnie has been a director on the boards of diverse companies, including Silicon Graphics International (SGI on NASDAQ), CDRV Investors and VWR International, Hubspan, Sonic Innovations, Talyst, and Virginia Mason Medical Center. Additionally, Lonnie shares his diverse expertise for the benefit of various public educational and research institutions. He serves on the boards of Harvard Medical School and Beth Isreal Deaconess Research and Educational Institute in Boston. Lonnie is Chairman of the Laboratory Advisory Committee of Pacific Northwest National Laboratory (PNNL), and has been on the Advisory Board of the Ford Motor Company Design Institute. At UW, Lonnie is very active, serving on the Advisory Boards for both the departments of Bioengineering and Physics, and for the recently formed "ultrasound-based Washington Molecular Imaging and Therapy Center," (uWAMIT). Among Lonnie's numerous awards and recognitions, he is the 2001 recipient of the George E. Pake prize, awarded by the American Physical Society.

Job Titles:

• Member of the Board of Directors
• Board Member, Element 8 Angels, and Principal, Canin Associates
• Independent Director / Board Member, Element 8 Angels, and Principal, Canin Associates

Jeff Canin has a long career in financial services and venture capital where he has worked extensively with IT, energy technology and materials science companies. His current efforts are focused on technology commercialization and project development, providing financial and business development advisory services to a number of early-stage companies and technology commercialization spinouts. A significant proportion of his time is involved in working with startups engaged in emerging cleantech sectors, including two novel water-treatment startups in the northwest. He is a member of the Board of Directors at Element 8, a cleantech-oriented angel investment group, as well as one of the co-managers of the Element 8 Venture Fund I, and has served as an entrepreneur-in-residence at the University of Washington, Washington State University, and Oregon State University. Mr. Canin previously was employed research director at Reed Global Advisors, an investment banking and research boutique focused on providing investment advisory services to energy and information technology companies, specializing in those seeking investment or strategic partnering in Japan. He was a general partner of Efund LLC, a local venture capital fund focused on early-stage software and telecom investments. He spent two years in the Northwest office of US Venture Partners, one of the largest California-based venture capital firms. Before moving to the Puget Sound area in 1995, Mr. Canin worked in San Francisco, California with Salomon Brothers, Inc. as a Senior Technology Analyst where he received recognition as "All Star Analyst: Computer Hardware" by the Wall Street Journal and ranked among Bloomberg Business News' "Top-50 Stock Pickers". Prior to Salomon Brothers, Mr. Canin worked at Montgomery Securities, performing securities analysis, with emphasis on computer hardware and software and was actively involved in corporate finance and merger and acquisition projects, and as a Senior Technology Analyst with Hambrecht & Quist, Inc. At the beginning of his career he was employed by the IBM National Accounts Division as a Marketing Representative and Systems Engineer. Jeff Canin earned an MBA in Marketing and International Business from the University of California, Berkeley, CA and his Bachelors Degree in Engineering and Economics from Brown University in Providence, RI, where he graduated Magna Cum Laude and Phi Beta Kappa. He has his NASD Registered Representative (Series 7, Series 63), NASD Investment Advisor (Series 65), and NYSE Registered Supervisory Analyst (Series 16) licenses.

Job Titles:

• Independent Director
• Member of the Board of Directors

Joe Wallin is a startup and corporate transactions and securities attorney in Seattle. His practice falls into several categories:

Job Titles:

• Point B Inc As Its First Employee
• President, Point B Capital

John Bjornson joined Point B Inc as its first employee in 1995 and has been Founding President of Point B Capital LLC, since 2010. Point B Capital is a venture capital fund that leverages the deep expertise, relationships, and resources of Point B Consulting to augment investment deal flow and selection and accelerate portfolio company success. Point B Consulting is consistently named as a best workplace and has over 550 associates averaging 17 years of experience who serve over 200 clients annually across 8 markets and 27 industries. Prior to launching Point B Capital, John was a Managing Director of Point B Consulting, and managed all aspects of project delivery for 200 engagements across 35 Point B clients. He also opened Point B's second Consulting market practice and established Point B's recruiting and client service quality functions. John was a Manager at Andersen Consulting prior to joining Point B. He previously served on the National Board for the National MS Society and Fast Forward (National MS Society's Venture Philanthropy fund) and Chaired the Board of Directors for the Greater Northwest Chapter. He has a BS from Pacific Lutheran University, is married, and together with his wife are helping their 3 children battle puberty.

Job Titles:

• Co - Founder & General Parter, Yaletown Venture Group
• Co - Founder & General Partner, Yaletown Venture Group
• Co - Founder and General Partner of Yaletown Venture Partners

Kirk Washington is a co-founder and General Partner of Yaletown Venture Partners, an early stage venture capital firm with offices in Vancouver, Calgary, and Seattle. He focuses on clean technology investments. Mr. Washington was responsible for Yaletown's investments in 6N Silicon (acquired by Silicor) and Microstaq (acquired by Zhejiang DunAn), and manages Yaletown's investments in Cooledge Lighting, Columbia Green, Endurance Wind Power and EnerG2. Prior to founding Yaletown, Mr. Washington spent 13 years with Ballard Power Systems (NASDAQ:BLDP) where he directed numerous activities including development of natural gas fueled stationary powerplants for distributed power generation, advanced vehicle propulsion systems including hybrid-electric propulsion systems for manned military submarines, and various special projects, then went on to lead corporate development including mergers & acquisitions, post-merger integration, and negotiation of joint development, technology licensing, and strategic supply agreements. Prior to Ballard Power Systems, Mr. Washington managed engineering teams and major projects at MacDonald Dettwiler in Vancouver, several disk drive companies in the Silicon Valley, and began his career with IBM Corporation in San Jose CA. Kirk is a mechanical engineer, and holds 11 patents related to his work in clean energy technology.

Job Titles:

• General Manager
• Member of the Board of Directors
• General Manager & Former UW Vice Provost - Commercialization

Linden Rhoads is the former vice provost of the UW Center for Commercialization, the unit of the University that seeks to commercialize discoveries emerging from research conducted at the UW. Previously, Rhoads was a veteran executive in the Seattle high-tech community. She co-founded or served as an active director or interim CEO of several successful Seattle-based startups, including ChiliSoft, Singingfish.com, AdRelevance, GBI, and Nimble Technology. Through her firm Seattle Ventures, she has been an active investor in high-tech companies for over a decade. Linden is a member of the Alliance of Angels and an LP in a number of prominent VC entrepreneur sidecar funds.

Job Titles:

• Managing Director at WRF Capital

Ms. Little focuses on investment opportunities in the life sciences such as medical devices, health care IT, biotechnology and scientific instrumentation. Her portfolio includes consumer technology, software and advanced materials companies. She has worked closely with several of WRF Capital's investments, including Clarisonic (acquired by L'Oreal), Mirador Biomedical (acquired by Centurion Medical Products), Amnis (acquired by EMD Millipore), Mobisante (acquired by Renew Group), and EKOS (acquired by BTG plc). She oversees WRF Capital's investments in Cardiac Insight, FlexMinder, Modumetal, Nexgenia, C-SATS, Cardeas Pharma, Accium Biosciences, Shippable, Phytelligence and Transformative Med. Previously, Ms. Little served as senior technology licensing manager at Washington Research Foundation. Before joining WRF, she worked as a marketing manager for a biotechnology company and as a market consultant. Ms. Little received an MBA from the University of Arizona and a B.A. in Zoology from Pomona College. She currently serves as a board member with the Alliance of Angels and WINGS-The Washington Medical Technology Angel Network.

Job Titles:

• Principal at Alexandria Venture Investments
• Principal, Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments
• Principal, Science and Technology at Alexandria Real Estate Equities, Inc

Monica Beam, PhD, is Principal, Science and Technology at Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments. She is responsible for providing scientific expertise and industry insights to support the company's real estate operations, business development, and thought leadership initiatives and relationship building across Alexandria's Mission Bay and greater Bay Area life science cluster. In addition, she is responsible for strategic venture and limited partner investments and tenant underwriting. Prior to joining Alexandria, Dr. Beam was Vice President at Square 1 Bank as a part of the Bay Area Life Science practice. In this role she helped build out the Bay Area Life Science practice and worked closely with early stage venture backed life science companies and VCs to structure, underwrite and monitor debt transactions. She earned a PhD and MS in Biomedical Engineering from Northwestern University, and a BS in Chemical Engineering from Stanford University. Dr. Beam's research and publications were focused on the fields of protein misfolding, neurodegenerative disease, biochemistry and florescence based imaging techniques.

Job Titles:

• Venture Partner, Madrona Venture Group

Patrick has more than 25 years of experience as a scientist, engineer, businessman, and venture capitalist. He is currently Venture Partner at Madrona. Prior to Madrona, Patrick was at Intellectual Ventures for more than a decade running startup incubation, seed investing and technology commercialization with a special focus on Asian markets. Previously Patrick was a Managing Director of ARCH Venture Partners where he funded and built early stage startups for ten years. His investments included Impinj (Nasdaq: PI), and Innovalight (acquired by DuPont). Before joining the venture capital industry as a Kauffman Fellow in 1998, Patrick held positions with AT&T and Bell Labs. Patrick led engineering projects in software development, speech recognition and network design. He also worked as a product manager in optical networking and a marketing manager for consumer telecom services. Before joining Bell Labs, Patrick conducted research in Nuclear Physics at government labs in North America and Europe. During this time, he published many articles in scientific journals including The Physical Review, Zeitschrift für Physik and Nuclear Instruments and Methods. Patrick has served on the boards of 18 venture backed companies, in addition to several non-profit boards. His current memberships include: Wipro Ltd and the University of Helsinki Commercialization Board. He is an inventor on several patents, has written about innovation and is a frequent speaker at conferences. He is also the founding CTO of Xinova, an Intellectual Ventures spinout that pioneered an international open-innovation market network. Patrick holds a PhD, MS, and MPhil in Physics from Yale, an MBA from Wharton, and a BS in Mathematics and Physics from the College of William and Mary where he was elected to Phi Beta Kappa.

Job Titles:

• President & CEO, Washington Research Foundation / WRF Capital

Ron Howell joined the Washington Research Foundation (WRF), an independent non-profit, in 1989. He shaped the organization's tremendously successful licensing programs, which have generated over $300M in revenue to support scholarship and research in Washington's universities and non-profit research institutions. In 1994, under Ron's leadership, the WRF leveraged staff expertise in evaluating research and intellectual property, and established WRF Capital, a return-on-investment mission early-stage venture capital organization.

Job Titles:

• Managing Director at Madrona Venture Group

Scott Jacobson has been a managing director at Madrona Venture Group since 2007 and currently serves on the boards of Haiku Deck, Indochino, LUMO BodyTech, Mobilewalla, RewardLoop and Yieldex; he is also a board observer for Animoto, BuddyTV, Mercent, Placed, Redfin and ShopIgniter. Scott also served on the board of Jambool prior to its acquisition by Google in 2010. Scott is particularly interested in consumer web, digital media and mobile technologies that present opportunities for major disruption of large, established markets. Prior to joining Madrona, Scott worked at Amazon.com, where he held senior product and business management positions in the Amazon Kindle and Amazon Marketplace groups. He led several key initiatives, including the international rollout of Amazon's Merchants@ platform. Earlier in his career, Scott was a Senior Consultant in Accenture's strategy consulting practice, where he worked with clients in enterprise software, retail, and energy sectors. Scott graduated cum laude from Northwestern University, where he received his bachelor's degree in Applied Mathematics and Economics. He received an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar.

Job Titles:

• ARCH As a Venture Partner
• Managing Director, ARCH Venture Partners

Steve Gillis joined ARCH as a Venture Partner in 2005 and has been a managing director since 2006. Steve is focused on the evaluation of new life science technologies and also on the development and growth of ARCH's biotechnology portfolio companies. Steve helped organize the start-up or early funding rounds of Theraclone-Sciences, VLST, Variation Biotechnologies, VentiRx Pharmaceuticals, and Lycera, among others. Steve is currently a director of Accelerator, Allozyne, Variation Biotechnologies, Pulmatrix and Bluebirdbio. He serves as director and Chairman of VentiRx Pharmaceuticals, Theraclone Sciences, PhaseRx and VLST. As a former director and Chairman of Trubion Pharmaceuticals (TRBN), he led its acquisition by Emergent BioSolutions in the fall of 2010. Steve was a founder and director of Corixa Corporation and served as the company's CEO from its inception and as its Chairman from 1999 until its acquisition in 2005 by GlaxoSmithKline. Prior to Corixa, Steve was a founder and director of Immunex Corporation. From 1981 until his departure in 1994, he served as Immunex's Director of Research and Development, Chief Scientific Officer, and as interim CEO following Immunex's majority purchase by American Cyanamid.

Job Titles:

• CEO of Aqueduct Critical Care, Inc. a Company
• Medical Device Executive and Former Chairman of WBBA

Tom Clement is one of the region's top medical device entrepreneurs with more than 30 years of experience and expertise in product development engineering, engineering management, and senior management. Tom is currently the CEO of Aqueduct Critical Care, Inc. a company he helped spin out of the University of Washington in 2011. Aqueduct is developing external drains for managing Cerebral Spinal (brain) Fluid post brain injury and brain surgery. Tom joined the UW Center for Commercialization in 2009 as an Entrepreneur-in-Residence, and then assumed the position of Director of New Ventures in the life sciences arena. Tom co-founded Pathway Medical Technologies, Inc. in 1998 and served as CEO until September 2008 as the company developed and brought to market its flagship product, the Jetstream System for treatment of peripheral arteries. Pathway was acquired by Bayer of Germany in 2011. Tom previously was a founding employee and held senior management roles at Heart Technology, which grew to more than $80 million in annual revenue and 550 employees before being acquired by Boston Scientific Corporation. After the acquisition, Tom took on responsibility for the Emerging Cardiovascular Technologies group of the Scimed Division of BSC. Tom is the past Chair of the Board of Directors for the Washington Biotechnology and Biomedical Association (now Life Science Washington) and is on the board of several life science start-up companies. He is a founder and Board co-Chair of the Medical Technology Angel Network, WINGS. He is also a board member of the Medical Technology Innovation Partnership Zone in Bothell, WA.

Job Titles:

• Member of the Board of Directors
• Administrative Partner, Madrona Capital
• Independent Director / Administrative Partner, Madrona Capital

Troy Cichos joined Madrona in 1999 and serves as the firm's administrative partner. In this role, Troy oversees the operations, finance and administration for Madrona and the venture funds under Madrona's management. Troy was formerly with Deloitte & Touche in Seattle where he served for six years as an associate and then tax manager. Mr. Cichos also worked for three years as a manager at ITT Financial. Troy also serves on the Advisory Board for the Center for Innovation and Entrepreneurship at the University of Washington's Foster School of Business which promotes entrepreneurial learning and discovery to UW students. Troy received his bachelor's degree in Finance from the University of Utah. He earned his law degree from Seattle University School of Law, where he graduated magna cum laude and was an editor of the Seattle University Law Review.

Job Titles:

• Independent Director
• Member of the Board of Directors
• Independent Social - Technologist
• Social - Technologist
• Social Technologist and Managing Partner of Unitus Seed Fund

Will Poole is a Social Technologist and managing partner of Unitus Seed Fund. He also serves as Chairman of NComputing, a leader in low-cost, low-energy computing and co-founded Bangalore-based Pengala Learning, whose mission is to change the way India learns. He leads Social Venture Partners Seattle's initiatives around social entrepreneurism including Social Innovation Fast Pitch, serves on the investment committee of the W-Fund, co-founded SVP Bangalore, and serves on three nonprofit boards. Will was previously a corporate vice president at Microsoft where he led several businesses, including Windows. His career started by founding two startups at the dawn of the PC era, working in the early days at Sun Microsystems, and pioneering e-commerce at eShop which was acquired by Microsoft in 1996. Will advises Western Governors University and Brown University on technology and is a Trustee of Bainbridge Graduate Institute. Will received a degree in Computer Science from Brown University.